The Times Australia
Google AI
News From Asia

.

Takeda Ukraine & Bulgaria Earn #8 Global Ranking in Best Places to Work 2024

LONDON, UK - Media OutReach Newswire - 5 June 2025 - Takeda, a global value-based, R&D-driven biopharmaceutical company, has been proudly recognized as one of the Top 10 Best Places to Work in the World for 2024, achieving the No.

8 global ranking by both Ukraine and Bulgaria countries. This prestigious recognition underscores Takeda's commitment to creating a workplace that embraces diversity, equity and inclusion (DE&I), fostering an empowering culture across all locations it operates. This accolade reflects Takeda's consistent focus on employee well-being, trust-based leadership, and a people-centered approach to business.

At Takeda, we are committed to delivering an exceptional employee experience by cultivating an inclusive, purpose-driven workplace where our people can grow both personally and professionally. Being recognized as a Best Place to Work reflects our unwavering dedication to building a culture where every colleague feels valued, supported, and empowered to thrive.

Volodymyr Pedko, General Manager of Takeda Ukraine, shared:
"It gives me great pride to receive this recognition during such challenging times! It stands as a testament to the exceptional quality of work and everyone's commitment to building and sustaining an innovative and inclusive workplace in our organization."

Todor Kesimov, General Manager of Takeda Romania & Bulgaria, commented:
"I am extremely proud that Takeda has been recognized as one of the top ten employers in the world for 2024. This confirms our efforts to build a culture of trust, care, and respect in every country, including Bulgaria. This recognition inspires us to continue building a better future – for our employees, for patients, and for society."
Hashtag: #BestPlacesToWork


The issuer is solely responsible for the content of this announcement.

About Takeda

Takeda is focused on creating better health for people and a brighter future for the world. We aim to discover and deliver life-transforming treatments in our core therapeutic and business areas, including gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines. Together with our partners, we aim to improve the patient experience and advance a new frontier of treatment options through our dynamic and diverse pipeline. As a leading values-based, R&D-driven biopharmaceutical company headquartered in Japan, we are guided by our commitment to patients, our people and the planet. Our employees in approximately 80 countries and regions are driven by our purpose and are grounded in the values that have defined us for more than two centuries. For more information, visit .

For more information, please visit the program website: .

Times Magazine

How new rules could stop AI scrapers destroying the internet

Australians are among the most anxious in the world[1] about artificial intelligence (AI). This...

Why Car Enthusiasts Are Turning to Container Shipping for Interstate Moves

Moving across the country requires careful planning and plenty of patience. The scale of domestic ...

What to know if you’re considering an EV

Soaring petrol prices are once again making many Australians think seriously[1] about switching ...

Epson launches ELPCS01 mobile projector cart

Designed for the EB-810E[1] projector and provides easy setup for portable displays in flexible ...

Governance Models for Headless CMS in Large Organizations

Where headless CMS is adopted by large enterprises, governance is the single most crucial factor d...

Narwal Freo Z10 Robotic Vacuum and Mop Cleaner

Narwal Freo Z10 Robotic Vacuum and Mop Cleaner  Rating: ★★★★☆ (4.4/5) Category: Premium Robot ...

The Times Features

Grants open for port communities across the Hunter and Northern Rivers regions

Local organisations doing important work across the Hunter and Northern Rivers regions are being...

AI Is Already Here. The Question Is Whether Your Business Is Built for It

We sat down with Nirlep Adhikari — CTO at LoanOptions.ai and Founder of Mount Mindforce — to cut...

Cleared to Land — and Cleared to Die: How a Runway Failure Killed Two Pilots in Seconds

A modern passenger jet, operating under full clearance, descending onto a controlled runway at o...

Leader of The Nationals Matt Canavan - press conference

CANBERRA PARLIAMENT HOUSE PRESS CONFERENCE WITH SHADOW WATER MINISTER MICHAEL McCORMACK; MURRAY-DA...

The Power Of An Uncomfortable Love

How challenging relationships can help us grow. Never have we lived in a time where relationshi...

US country favourite Larry Fleet joins 2026 Gympie Music Muster

Tennessee singer-songwriter Larry Fleet will bring his band to the Gympie Music Muster on Friday...

56 OF YOUR FAVORITE DISNEY STARS SHINE BRIGHT IN DISNEY ON ICE PRESENTS MAGIC IN THE STARS!

The most Disney characters in one show and the on-ice debut of Raya from Raya and the Last Dragon...

How much do you really need to retire? It’s probably a lot less than $1 million

Every few months, someone in the superannuation industry declares that Australians now “need” ar...

South Australian Nationals to open up local oil from Great Australian Bight

Amid out-of-control inflation and impacts from the Middle East conflict, The South Australian Na...